longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

SttStrtSPDRS&PUSHlthCareSelectSectETF(SSEHF.US)

Last Updated 19:00:00 ET
longbridge loading
News
Holdings
Overview

How healthcare became the most reliable source of paychecks in the US

Invezz·04/07/2026 22:50
US
PBE
+0.50%
US
VHT
+0.71%
SZ
159898
+0.58%
Invezz·04/07/2026 22:50
US
PBE
+0.50%
US
VHT
+0.71%
SZ
159898
+0.58%

Medicare Advantage's once-blistering growth dropped in 2026. Here's what that means.

Dow Jones·02/21/2026 02:10
US
IBB
+0.91%
US
PBE
+0.50%
US
XBI
+1.14%
Dow Jones·02/21/2026 02:10
US
IBB
+0.91%
US
PBE
+0.50%
US
XBI
+1.14%

ESIH, XSDR, HLTH: These ETFs Provide Exposure to Europe's Top Healthcare Companies

Tip Ranks·02/12/2026 05:39
US
SSEHF
+2.05%
US
NVS
+1.37%
US
XHE
+0.28%
Tip Ranks·02/12/2026 05:39
US
SSEHF
+2.05%
US
NVS
+1.37%
US
XHE
+0.28%
© 2026 Longbridge|Disclaimer

Event Tracking

May21
Gilead Completes Acquisition of Tubulis, Investing $3.15 Billion to Enhance Oncology Portfolio
13:32
Erasca and Merck Collaborate to Study ERAS-0015 Combined with KEYTRUDA for RAS-Mutant Solid Tumors
12:37
Eli Lilly Announces Positive Phase 3 Results for Retatrutide, Showing Significant Weight Loss in Obese Patients
11:37
Johnson & Johnson Partners with Abu Dhabi Health Services to Launch Global Open Surgical Intelligence Network
11:07
Eli Lilly's Retatrutide 12mg Dose Achieves 30.3% Average Weight Loss at 104 Weeks
10:46
Eli Lilly: Patients on Highest Dose of Retatrutide Achieve 28.3% Weight Loss
10:46